| 000 | 01834 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517074748.0 | ||
| 264 | 0 | _c20170329 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/jth.13272 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiedermann, J S | |
| 245 | 0 | 0 |
_aImpact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cApr 2016 |
||
| 300 |
_a695-703 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xchemistry |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHeart Valve Prosthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonitoring, Physiologic _xmethods |
| 650 | 0 | 4 | _aPoint-of-Care Systems |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aQuality of Health Care |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVenous Thromboembolism _xdrug therapy |
| 650 | 0 | 4 |
_aVitamin K _xantagonists & inhibitors |
| 700 | 1 | _avan Rein, N | |
| 700 | 1 | _avan den Besselaar, A M H P | |
| 700 | 1 | _aBuhre, P N | |
| 700 | 1 | _ade Maat, M P M | |
| 700 | 1 | _avan der Meer, F J M | |
| 700 | 1 | _aLeebeek, F W G | |
| 700 | 1 | _aKruip, M J H A | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 14 _gno. 4 _gp. 695-703 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jth.13272 _zAvailable from publisher's website |
| 999 |
_c25665475 _d25665475 |
||